Global cerebral ischemia: Synaptic and cognitive dysfunction

Current Drug Targets

Volumn 14, Issue 1, 2013, Pages 20-35

  Neumann, Jake T ^a   Cohan, Charles H ^a   Dave, Kunjan R ^a   Wright, Clinton B ^a   Perez Pinzon, Miguel A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Cardiac arrest; Global cerebral ischemia; Hippocampus; Neuroprotection; Synapse

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMPA RECEPTOR; HEAT SHOCK PROTEIN 70; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; SYNAPSIN I; SYNAPTOTAGMIN;

AGING; ANXIETY; ASPHYXIA; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; COGNITIVE DEFECT; DEPRESSION; EXPERIMENTAL MODEL; HEART ARREST; HIPPOCAMPAL CA1 REGION; HUMAN; HYPERPOLARIZATION; HYPOTENSION; INCIDENCE; ION CONDUCTANCE; ISCHEMIC PRECONDITIONING; MAZE TEST; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SPATIAL MEMORY; WORKING MEMORY;

AGING; ANIMALS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; COGNITION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; NEUROPROTECTIVE AGENTS; SYNAPTIC TRANSMISSION;

EID: 84876710820     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: None     Document Type: Review

References (281)

1. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 2008; 52(14): 1179-99.
2. Reinier K, Thomas E, Andrusiek DL, et al. Socioeconomic status and incidence of sudden cardiac arrest. CMAJ 2011; 183(15): 1705-12.
3. Delhaye C, Mahmoudi M, Waksman R. Hypothermia therapy: neurological and cardiac benefits. J Am Coll Cardiol 2012; 59(3): 197-210.
4. McNally B, Robb R, Mehta M, et al. Out-of-hospital cardiac arrest surveillance-Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005-December 31, 2010. MMWR Surveill Summ 2011; 60(8): 1-19.
5. Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 2008; 300(12): 1423-31.
6. Rea TD, Page RL. Community approaches to improve resuscitation after out-of-hospital sudden cardiac arrest. Circulation 2010; 121(9): 1134-40.
7. Sasson C, Rogers MA, Dahl J, Kellermann AL. Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2010; 3(1): 63-81.
8. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125(1): e2-e220.
9. Deo R, Albert CM. Epidemiology and genetics of sudden cardiac death. Circulation. 2012; 125(4): 620-37.
10. Becker LB, Han BH, Meyer PM, et al. Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. N Engl J Med 1993; 329(9): 600-6.
11. Printz BF. Noninvasive imaging modalities and sudden cardiac arrest in the young: can they help distinguish subjects with a potentially life-threatening abnormality from normals? Pediatr Cardiol 2012; 33(3): 439-51.
12. Estes NA, 3rd. Predicting and preventing sudden cardiac death. Circulation 2011; 124(5): 651-6.
13. Shah AM, Estes NA, 3rd, Weinstock J, Homoud MK, Link MS. Treatment of athletes with cardiac disease or arrhythmias. Curr Treat Options Cardiovasc Med 2006; 8(5): 353-61.
14. Richmond TS. Cerebral resuscitation after global brain ischemia: linking research to practice. AACN Clin Issues 1997; 8(2): 171-81.
15. Hossmann KA. Reperfusion of the brain after global ischemia: hemodynamic disturbances. Shock 1997; 8(2): 95-101; discussion 2-3.
16. Hansen AJ. Effect of anoxia on ion distribution in the brain. Physiol Rev 1985; 65(1): 101-48.
17. Choi DW. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 1985; 58(3): 293-7.
18. Turturro A, Witt WW, Lewis S, et al. Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci 1999; 54(11): B492-501.
19. Goodrick CL, Ingram DK, Reynolds MA, Freeman JR, Cider NL. Differential effects of intermittent feeding and voluntary exercise on body weight and lifespan in adult rats. J Gerontol 1983; 38(1): 36-45.
20. Quinn R. Comparing rat's to human's age: how old is my rat in people years? Nutrition 2005; 21(6): 775-7.
21. Mos J, Hollander CF. Analysis of survival data on aging rat cohorts: pitfalls and some practical considerations. Mech Ageing Dev 1987; 38(1): 89-105.
22. Walford RL. Letter: When is a mouse "old"? J Immunol 1976; 117(1): 352.
23. Fisher M, Feuerstein G, Howells DW, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009; 40(6): 2244-50.
24. Xu K, Puchowicz MA, Sun X, LaManna JC. Mitochondrial dysfunction in aging rat brain following transient global ischemia. Adv Exp Med Biol 2008; 614: 379-86.
25. Xu K, Sun X, Puchowicz MA, LaManna JC. Increased sensitivity to transient global ischemia in aging rat brain. Adv Exp Med Biol 2007; 599: 199-206.
26. Xu K, Puchowicz MA, Sun X, LaManna JC. Decreased brainstem function following cardiac arrest and resuscitation in aged rat. Brain Res 2010; 1328: 181-9.
27. Price Schedule-Aging Colonies-Non-NIA Funded Grantees-Effective 9/1/2010. 2010 [May 25, 2012]; Available from: http: //www.nia.nih.gov/research/dab/aged-rodent-colonieshandbook/ price-schedule-aging-colonies-non-nia-funded-grantees.
28. Rosenzweig ES, Barnes CA. Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog Neurobiol 2003; 69(3): 143-79.
29. Mizoguchi K, Shoji H, Tanaka Y, Maruyama W, Tabira T. Agerelated spatial working memory impairment is caused by prefrontal cortical dopaminergic dysfunction in rats. Neuroscience 2009; 162(4): 1192-201.
30. Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke. 1989; 20(12): 1627-42.
31. McBean DE, Kelly PA. Rodent models of global cerebral ischemia: a comparison of two-vessel occlusion and four-vessel occlusion. Gen Pharmacol 1998; 30(4): 431-4.
32. Wellons JC, 3rd, Sheng H, Laskowitz DT, et al. A comparison of strain-related susceptibility in two murine recovery models of global cerebral ischemia. Brain Res 2000; 868(1): 14-21.
33. Kofler J, Hattori K, Sawada M, et al. Histopathological and behavioral characterization of a novel model of cardiac arrest and cardiopulmonary resuscitation in mice. J Neurosci Methods. 2004; 136(1): 33-44.
34. de Garavilla L, Babbs CF, Tacker WA. An experimental circulatory arrest model in the rat to evaluate calcium antagonists in cerebral resuscitation. Am J Emerg Med 1984; 2(4): 321-6.
35. Dezfulian C, Shiva S, Alekseyenko A, et al. Nitrite therapy after cardiac arrest reduces reactive oxygen species generation, improves cardiac and neurological function, and enhances survival via reversible inhibition of mitochondrial complex I. Circulation 2009; 120(10): 897-905.
36. Pichiule P, Chavez JC, Xu K, LaManna JC. Vascular endothelial growth factor upregulation in transient global ischemia induced by cardiac arrest and resuscitation in rat brain. Brain Res Mol Brain Res 1999; 74(1-2): 83-90.
37. von Planta I, Weil MH, von Planta M, et al. Cardiopulmonary resuscitation in the rat. J Appl Physiol 1988; 65(6): 2641-7.
38. Chen MH, Liu TW, Xie L, et al. A simpler cardiac arrest model in rats. Am J Emerg Med 2007; 25(6): 623-30.
39. Chen MH, Liu TW, Xie L, et al. Ventricular fibrillation induced by transoesophageal cardiac pacing: a new model of cardiac arrest in rats. Resuscitation 2007; 74(3): 546-51.
40. Schmitz B, Bottiger BW, Hossmann KA. Functional activation of cerebral blood flow after cardiac arrest in rat. J Cereb Blood Flow Metab 1997; 17(11): 1202-9.
41. Katz L, Ebmeyer U, Safar P, Radovsky A, Neumar R. Outcome model of asphyxial cardiac arrest in rats. J Cereb Blood Flow Metab 1995; 15(6): 1032-9.
42. Dave KR, Raval AP, Prado R, et al. Mild cardiopulmonary arrest promotes synaptic dysfunction in rat hippocampus. Brain Res 2004; 1024(1-2): 89-96.
43. Reid KH, Young C, Schurr A, et al. Audiogenic seizures following global ischemia induced by chest compression in Long-Evans rats. Epilepsy Res 1996; 23(3): 195-209.
44. Krajewski S, Mai JK, Krajewska M, et al. Upregulation of bax protein levels in neurons following cerebral ischemia. J Neurosci 1995; 15(10): 6364-76.
45. Soltys Z, Janeczko K, Orzylowska-Sliwinska O, et al. Morpholo gical transformations of cells immunopositive for GFAP, TrkA or p75 in the CA1 hippocampal area following transient global ischemia in the rat. A quantitative study. Brain Res 2003; 987(2): 186-93.
46. Schleien CL, Eberle B, Shaffner DH, Koehler RC, Traystman RJ. Reduced blood-brain barrier permeability after cardiac arrest by conjugated superoxide dismutase and catalase in piglets. Stroke 1994; 25(9): 1830-4; discussion 4-5.
47. Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S. Cerebral ischemia and reperfusion: prevention of brain mitochon drial injury by lidoflazine. J Cereb Blood Flow Metab 1987; 7(6): 752-8.
48. Kumar K, Krause G, Koestner A, Hoehner T, White B. Effect of flunarizine on global brain ischemia in the dog: a quantitative morphologic assessment. Exp Neurol 1987; 97(1): 115-27.
49. Vaagenes P, Safar P, Diven W, et al. Brain enzyme levels in CSF after cardiac arrest and resuscitation in dogs: markers of damage and predictors of outcome. J Cereb Blood Flow Metab 1988; 8(2): 262-75.
50. Schleien CL, Koehler RC, Shaffner DH, Traystman RJ. Bloodbrain barrier disruption following CPR in piglets. Acta Neurochir Suppl (Wien) 1990; 51: 213-5.
51. Schmid G, Neubauer G, Illievich UM, Alesch F. Dielectric properties of porcine brain tissue in the transition from life to death at frequencies from 800 to 1900 MHz. Bioelectromagnetics 2003; 24(6): 413-22.
52. Golden WC, Brambrink AM, Traystman RJ, Shaffner DH, Martin LJ. Nitration of the striatal Na, K-ATPase alpha3 isoform occurs in normal brain development but is not increased during hypoxiaischemia in newborn piglets. Neurochem Res 2003; 28(12): 1883-9.
53. Cobianchi L, Zonta S, Vigano J, et al. Experimental small bowel transplantation from non-heart-beating donors: a large-animal study. Transplant Proc 2009; 41(1): 55-6.
54. Calle PA, Bogaert MG, Van Reempts JL, Buylaert WA. Neurological damage in a cardiopulmonary arrest model in the rat. J Pharmacol Methods 1989; 22(3): 185-95.
55. Petito CK, Feldmann E, Pulsinelli WA, Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 1987; 37(8): 1281-6.
56. Megias M, Emri Z, Freund TF, Gulyas AI. Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience 2001; 102(3): 527-40.
57. Schmidt-Kastner R, Freund TF. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 1991; 40(3): 599-636.
58. Hansen AJ, Hounsgaard J, Jahnsen H. Anoxia increases potassium conductance in hippocampal nerve cells. Acta Physiol Scand 1982; 115(3): 301-10.
59. Fujiwara N, Higashi H, Shimoji K, Yoshimura M. Effects of hypoxia on rat hippocampal neurones in vitro. J Physiol 1987; 384: 131-51.
60. Leblond J, Krnjevic K. Hypoxic changes in hippocampal neurons. J Neurophysiol 1989; 62(1): 1-14.
61. Hyllienmark L, Brismar T. Effect of hypoxia on membrane potential and resting conductance in rat hippocampal neurons. Neu roscience 1999; 91(2): 511-7.
62. Collewijn H, Harreveld AV. Membrane potential of cerebral cortical cells during reading depression and asyxia. Exp Neurol 1966; 15(4): 425-36.
63. Kass IS, Lipton P. Protection of hippocampal slices from young rats against anoxic transmission damage is due to better maintenance of ATP. J Physiol 1989; 413: 1-11.
64. Kobayashi T, Kuroda S, Tada M, et al. Calcium-induced mitochondrial swelling and cytochrome c release in the brain: its biochemical characteristics and implication in ischemic neuronal injury. Brain Res 2003; 960(1-2): 62-70.
65. Ekstrom von Lubitz DK, Diemer NH. Complete cerebral ischaemia in the rat: an ultrastructural and stereological analysis of the distal stratum radiatum in the hippocampal CA-1 region. Neuropathol Appl Neurobiol 1982; 8(3): 197-215.
66. Werth JL, Park TS, Silbergeld DL, Rothman SM. Excitotoxic swelling occurs in oxygen and glucose deprived human cortical slices. Brain Res 1998; 782(1-2): 248-54.
67. Park JS, Bateman MC, Goldberg MP. Rapid alterations in dendrite morphology during sublethal hypoxia or glutamate receptor activation. Neurobiol Dis 1996; 3(3): 215-27.
68. Jourdain P, Nikonenko I, Alberi S, Muller D. Remodeling of hippocampal synaptic networks by a brief anoxia-hypoglycemia. J Neurosci 2002; 22(8): 3108-16.
69. Kovalenko T, Osadchenko I, Nikonenko A, et al. Ischemia-induced modifications in hippocampal CA1 stratum radiatum excitatory synapses. Hippocampus 2006; 16(10): 814-25.
70. Braughler JM, Duncan LA, Goodman T. Calcium enhances in vitro free radical-induced damage to brain synaptosomes, mitochondria, and cultured spinal cord neurons. J Neurochem 1985; 45(4): 1288-93.
71. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982; 239(1): 57-69.
72. Kitagawa K, Matsumoto M, Sobue K, et al. The synapsin I brain distribution in ischemia. Neuroscience 1992; 46(2): 287-99.
73. Morioka M, Nagahiro S, Fukunaga K, Miyamoto E, Ushio Y. Calcineurin in the adult rat hippocampus: different distribution in CA1 and CA3 subfields. Neuroscience 1997; 78(3): 673-84.
74. Jung YJ, Park SJ, Park JS, Lee KE. Glucose/oxygen deprivation induces the alteration of synapsin I and phosphosynapsin. Brain Res. 2004; 996(1): 47-54.
75. Bolay H, Gursoy-Ozdemir Y, Sara Y, et al. Persistent defect in transmitter release and synapsin phosphorylation in cerebral cortex after transient moderate ischemic injury. Stroke 2002; 33(5): 1369-75.
76. Yokota N, Uchijima M, Nishizawa S, Namba H, Koide Y. Identification of differentially expressed genes in rat hippocampus after transient global cerebral ischemia using subtractive cDNA cloning based on polymerase chain reaction. Stroke 2001; 32(1): 168-74.
77. Ito U, Kuroiwa T, Nagasao J, Kawakami E, Oyanagi K. Temporal profiles of axon terminals, synapses and spines in the ischemic penumbra of the cerebral cortex: ultrastructure of neuronal remodeling. Stroke 2006; 37(8): 2134-9.
78. Marti E, Ferrer I, Blasi J. Transient increase of synapsin-I immunoreactivity in the mossy fiber layer of the hippocampus after transient forebrain ischemia in the mongolian gerbil. Brain Res 1999; 824(2): 153-60.
79. Ishimaru H, Casamenti F, Ueda K, Maruyama Y, Pepeu G. Changes in presynaptic proteins, SNAP-25 and synaptophysin, in the hippocampal CA1 area in ischemic gerbils. Brain Res 2001; 903(1-2): 94-101.
80. Radenovic L, Korenic A, Maleeva G, et al. Comparative ultrastructural analysis of mitochondria in the CA1 and CA3 hippocampal pyramidal cells following global ischemia in Mongolian gerbils. Anat Rec (Hoboken) 2011; 294(6): 1057-65.
81. Andine P, Jacobson I, Hagberg H. Enhanced calcium uptake by CA1 pyramidal cell dendrites in the postischemic phase despite subnormal evoked field potentials: excitatory amino acid receptor dependency and relationship to neuronal damage. J Cereb Blood Flow Metab 1992; 12(5): 773-83.
82. Andine P, Jacobson I, Hagberg H. Calcium uptake evoked by electrical stimulation is enhanced postischemically and precedes delayed neuronal death in CA1 of rat hippocampus: involvement of N-methyl-D-aspartate receptors. J Cereb Blood Flow Metab 1988; 8(6): 799-807.
83. Hori N, Doi N, Miyahara S, Shinoda Y, Carpenter DO. Appearance of NMDA receptors triggered by anoxia independent of voltage in vivo and in vitro. Exp Neurol 1991; 112(3): 304-11.
84. Hori N, Carpenter DO. Transient ischemia causes a reduction of Mg2+ blockade of NMDA receptors. Neurosci Lett 1994; 173(1-2): 75-8.
85. Tsubokawa H, Oguro K, Robinson HP, Masuzawa T, Kawai N. Single glutamate channels in CA1 pyramidal neurones after transient ischaemia. Neuroreport 1995; 6(3): 527-3.
86. Di Filippo M, Tozzi A, Costa C, et al. Plasticity and repair in the post-ischemic brain. Neuropharmacology 2008; 55(3): 353-62.
87. Ai J, Baker A. Long-term potentiation of evoked presynaptic response at CA3-CA1 synapses by transient oxygen-glucose deprivation in rat brain slices. Exp Brain Res 2006; 169(1): 126-9.
88. Shackelford DA, Yeh RY, Hsu M, Buzsaki G, Zivin JA. Effect of cerebral ischemia on calcium/calmodulin-dependent protein kinase II activity and phosphorylation. J Cereb Blood Flow Metab 1995; 15(3): 450-61.
89. Hsu KS, Huang CC. Protein kinase C inhibitors block generation of anoxia-induced long-term potentiation. Neuroreport 1998; 9(15): 3525-9.
90. Huang CC, Hsu KS. Nitric oxide signalling is required for the generation of anoxia-induced long-term potentiation in the hippo campus. Eur J Neurosci 1997; 9(10): 2202-6.
91. Kirkham F. Cardiac arrest and post resuscitation of the brain. Eur J Paediatr Neurol 2011; 15(5): 379-89.
92. Rittenberger JC, Popescu A, Brenner RP, Guyette FX, Callaway CW. Frequency and timing of nonconvulsive status epilepticus in comatose post-cardiac arrest subjects treated with hypothermia. Neurocrit Care 2012; 16(1): 114-22.
93. McNamara JO. Human hypoxia and seizures: effects and interac tions. Adv Neurol 1979; 26: 137-43.
94. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57(11): 1617-22.
95. Crepel V, Epsztein J, Ben-Ari Y. Ischemia induces short-and longterm remodeling of synaptic activity in the hippocampus. J Cell Mol Med 2003; 7(4): 401-7.
96. Mittmann T, Qu M, Zilles K, Luhmann HJ. Long-term cellular dysfunction after focal cerebral ischemia: in vitro analyses. Neuroscience 1998; 85(1): 15-27.
97. Congar P, Gaiarsa JL, Popovici T, Ben-Ari Y, Crepel V. Permanent reduction of seizure threshold in post-ischemic CA3 pyramidal neurons. J Neurophysiol 2000; 83(4): 2040-6.
98. Arabadzisz D, Freund TF. Changes in excitatory and inhibitory circuits of the rat hippocampus 12-14 months after complete forebrain ischemia. Neuroscience 1999; 92(1): 27-45.
99. Hsu M, Buzsaki G. Vulnerability of mossy fiber targets in the rat hippocampus to forebrain ischemia. J Neurosci 1993; 13(9): 3964-79.
100. Epsztein J, Milh M, Bihi RI, et al. Ongoing epileptiform activity in the post-ischemic hippocampus is associated with a permanent shift of the excitatory-inhibitory synaptic balance in CA3 pyramidal neurons. J Neurosci 2006; 26(26): 7082-92.
101. Yang Y, Li Q, Miyashita H, et al. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia. J Neurosurg 2000; 92(5): 841-7.
102. Yang Y, Li Q, Shuaib A. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharma cology 2000; 39(5): 881-8.
103. Mocco J, Shelton CE, Sergot P, et al. O-desulfated heparin improves outcome after rat cerebral ischemia/reperfusion injury. Neurosurgery 2007; 61(6): 1297-303; discussion 303-4.
104. Zhang ZG, Lu TS, Yuan HY. Neuroprotective effects of ultra-lowmolecular-weight heparin in vitro and vivo models of ischemic injury. Fundam Clin Pharmacol 2011; 25(3): 300-3.
105. Aldandashi S, Noor R, Wang CX, Uddin G, Shuaib A. Combination treatment with dipyridamole, aspirin, and tPA in an embolic model of stroke in rats. Exp Neurol 2007; 205(2): 563-8.
106. Garcia-Bonilla L, Sosti V, Campos M, et al. Effects of acute posttreatment with dipyridamole in a rat model of focal cerebral ischemia. Brain Res 2011; 1373: 211-20.
107. Levy DE, Trammel J, Wasiewski WW, Ancrod Stroke Program Study T. Ancrod for acute ischemic stroke: a new dosing regimen derived from analysis of prior ancrod stroke studies. J Stroke Cerebrovasc Dis 2009; 18(1): 23-7.
108. Hypothermia after Cardiac Arrest Study G. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346(8): 549-56.
109. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypo thermia. N Engl J Med 2002; 346(8): 557-63.
110. Groysman LI, Emanuel BA, Kim-Tenser MA, Sung GY, Mack WJ. Therapeutic hypothermia in acute ischemic stroke. Neurosurg Focus 2011; 30(6): E17.
111. Busto R, Dietrich WD, Globus MY, Ginsberg MD. Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury. Neurosci Lett 1989; 101(3): 299-304.
112. Kuluz JW, Prado R, Chang J, et al. Selective brain cooling increases cortical cerebral blood flow in rats. Am J Physiol 1993; 265(3 Pt 2): H824-7.
113. Erecinska M, Thoresen M, Silver IA. Effects of hypothermia on energy metabolism in Mammalian central nervous system. J Cereb Blood Flow Metab 2003; 23(5): 513-30.
114. Shao ZH, Sharp WW, Wojcik KR, et al. Therapeutic hypothermia cardioprotection via Akt-and nitric oxide-mediated attenuation of mitochondrial oxidants. Am J Physiol Heart Circ Physiol 2010; 298(6): H2164-73.
115. Yang D, Guo S, Zhang T, Li H. Hypothermia attenuates ischemia/ reperfusion-induced endothelial cell apoptosis via alterations in apoptotic pathways and JNK signaling. FEBS Lett 2009; 583(15): 2500-6.
116. Cao LJ, Wang J, Hao PP, Sun CL, Chen YG. Effects of ulinastatin, a urinary trypsin inhibitor, on synaptic plasticity and spatial memory in a rat model of cerebral ischemia/reperfusion injury. Chin J Physiol 2011; 54(6): 435-42.
117. Centonze D, Saulle E, Pisani A, et al. Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation. Neuro report 2002; 13(1): 115-8.
118. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci 2002; 5 Suppl: 1039-42.
119. Ginsberg MD. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 2009; 40(3 Suppl): S111-4.
120. Ginsberg MD. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 2008; 55(3): 363-89.
121. Davis SM, Lees KR, Albers GW, et al. Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 2000; 31(2): 347-54.
122. Fisher M, Schaebitz W. An overview of acute stroke therapy: past, present, and future. Arch Intern Med. 2000; 160(21): 3196-206.
123. Gladstone DJ, Black SE, Hakim AM, Heart, Stroke Foundation of Ontario Centre of Excellence in Stroke R. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002; 33(8): 2123-36.
124. Suzuki Y, Takagi Y, Nakamura R, Hashimoto K, Umemura K. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats. Brain Res 2003; 964(1): 116-20.
125. Recommendations for standards regarding preclinical neuropro tective and restorative drug development. Stroke. 1999; 30(12): 2752-8.
126. Cross AJ, Jones JA, Snares M, et al. The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity. Br J Pharmacol 1995; 114(8): 1625-30.
127. Marshall JW, Cross AJ, Ridley RM. Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species. Exp Neurol 1999; 156(1): 121-9.
128. Qi SH, Liu Y, Wang WW, Wang M, Zhang GY. Neuroprotection of ethanol against cerebral ischemia/reperfusion induced brain injury through GABA receptor activation. Brain Res 2009; 1276: 151-8.
129. Costa C, Leone G, Saulle E, et al. Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. Stroke 2004; 35(2): 596-600.
130. Kulinskii VI, Mikhel'son GV. Additivity and independence of neuroprotective effects of GABAA and GABAB receptor agonists in complete global cerebral ischemia. Bull Exp Biol Med 2000; 130(8): 772-4.
131. Knight SR, Davidson C, Young AM, Gibson CL. Allopreg nanolone protects against dopamine-induced striatal damage following in vitro ischaemia via interaction at GABA(A) receptors. J Neuroendocrinol 2012.
132. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 2010; 468(7321): 305-9.
133. Li Y, Lei Z, Xu ZC. Enhancement of inhibitory synaptic trans mission in large aspiny neurons after transient cerebral ischemia. Neuroscience 2009; 159(2): 670-81.
134. Zhang H, Schools GP, Lei T, et al. Resveratrol attenuates early pyramidal neuron excitability impairment and death in acute rat hippocampal slices caused by oxygen-glucose deprivation. Exp Neurol 2008; 212(1): 44-52.
135. Mandic M, Rancic N. [Risk factors for stroke]. Med Pregl 2011; 64(11-12): 600-5.
136. Alkan T. Neuroproctective effects of ischemic tolerance (precon ditioning) and postconditioning. Turk Neurosurg 2009; 19(4): 406-12.
137. Shpargel KB, Jalabi W, Jin Y, et al. Preconditioning paradigms and pathways in the brain. Cleve Clin J Med 2008; 75 Suppl 2: S77-82.
138. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74(5): 1124-36.
139. Schurr A, Reid KH, Tseng MT, West C, Rigor BM. Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res 1986; 374(2): 244-8.
140. Kato H, Liu Y, Araki T, Kogure K. MK-801, but not anisomycin, inhibits the induction of tolerance to ischemia in the gerbil hippocampus. Neurosci Lett 1992; 139(1): 118-21.
141. Bond A, Lodge D, Hicks CA, Ward MA, O'Neill MJ. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. Eur J Pharmacol 1999; 380(2-3): 91-9.
142. Yin XH, Zhang QG, Miao B, Zhang GY. Neuroprotective effects of preconditioning ischaemia on ischaemic brain injury through inhibition of mixed-lineage kinase 3 via NMDA receptor-mediated Akt1 activation. J Neurochem 2005; 93(4): 1021-9.
143. Goto Y, Niidome T, Akaike A, Kihara T, Sugimoto H. Amyloid beta-peptide preconditioning reduces glutamate-induced neuro toxicity by promoting endocytosis of NMDA receptor. Biochem Biophys Res Commun 2006; 351(1): 259-65.
144. Zhang QG, Wang RM, Han D, et al. Preconditioning neuro protection in global cerebral ischemia involves NMDA receptormediated ERK-JNK3 crosstalk. Neurosci Res 2009; 63(3): 205-12.
145. Navon H, Bromberg Y, Sperling O, Shani E. Neuroprotection by NMDA preconditioning against glutamate cytotoxicity is mediated through activation of ERK 1/2, inactivation of JNK, and by prevention of glutamate-induced CREB inactivation. J Mol Neuro sci 2012; 46(1): 100-8.
146. Raval AP, Dave KR, Mochly-Rosen D, Sick TJ, Perez-Pinzon MA. Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippo campal slice. J Neurosci. 2003; 23(2): 384-91.
147. Jiang X, Tian F, Mearow K, et al. The excitoprotective effect of Nmethyl-D-aspartate receptors is mediated by a brain-derived neuro trophic factor autocrine loop in cultured hippocampal neurons. J Neurochem 2005; 94(3): 713-22.
148. Marini AM, Rabin SJ, Lipsky RH, Mocchetti I. Activity-dependent release of brain-derived neurotrophic factor underlies the neuro protective effect of N-methyl-D-aspartate. J Biol Chem 1998; 273(45): 29394-9.
149. Saleh MC, Connell BJ, Saleh TM. Ischemic tolerance following low dose NMDA involves modulation of cellular stress proteins. Brain Res 2009; 1247: 212-20.
150. Duszczyk M, Gadamski R, Ziembowicz A, Danysz W, Lazarewicz JW. NMDA receptor antagonism does not inhibit induction of ischemic tolerance in gerbil brain in vivo. Neurotox Res 2005; 7(4): 283-92.
151. Prior M, Thatcher N, Morris P, Reese T, Bachelard H. The phenomenon of "pre-ischaemic conditioning" in the brain only partly involves the NMDA receptor: a magnetic resonance study. Neurochem Res 2005; 30(10): 1219-25.
152. Blondeau N, Plamondon H, Richelme C, Heurteaux C, Lazdunski M. K(ATP) channel openers, adenosine agonists and epileptic pre conditioning are stress signals inducing hippocampal neuro protection. Neuroscience 2000; 100(3): 465-74.
153. Nakagawa I, Nakase H, Aketa S, et al. ATP-dependent potassium channel mediates neuroprotection by chemical preconditioning with 3-nitropropionic acid in gerbil hippocampus. Neurosci Lett. 2002; 320(1-2): 33-6.
154. Reshef A, Sperling O, Zoref-Shani E. Adenosine-induced precon ditioning of rat neuronal cultures against ischemia-reperfusion injury. Adv Exp Med Biol 1998; 431: 365-8.
155. Perez-Pinzon MA, Mumford PL, Rosenthal M, Sick TJ. Anoxic preconditioning in hippocampal slices: role of adenosine. Neuro science 1996; 75(3): 687-94.
156. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA 1995; 92(10): 4666-70.
157. Allen D, Nakayama S, Kuroiwa M, et al. SK2 channels are neuroprotective for ischemia-induced neuronal cell death. J Cereb Blood Flow Metab 2011; 31(12): 2302-12.
158. Dave KR, DeFazio RA, Raval AP, et al. Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon. J Neurosci 2008; 28(16): 4172-82.
159. DeFazio RA, Raval AP, Lin HW, et al. GABA synapses mediate neuroprotection after ischemic and epsilonPKC preconditioning in rat hippocampal slice cultures. J Cereb Blood Flow Metab 2009; 29(2): 375-84.
160. Dave KR, Anthony Defazio R, Raval AP, et al. Protein kinase C epsilon activation delays neuronal depolarization during cardiac arrest in the euthermic arctic ground squirrel. J Neurochem 2009; 110(4): 1170-9.
161. Della-Morte D, Raval AP, Dave KR, Lin HW, Perez-Pinzon MA. Post-ischemic activation of protein kinase C epsilon protects the hippocampus from cerebral ischemic injury via alterations in cerebral blood flow. Neurosci Lett 2011; 487(2): 158-62.
162. Raval AP, Dave KR, DeFazio RA, Perez-Pinzon MA. epsilonPKC phosphorylates the mitochondrial K(+) (ATP) channel during induction of ischemic preconditioning in the rat hippocampus. Brain Res 2007; 1184: 345-53.
163. Alexander MP, Lafleche G, Schnyer D, Lim C, Verfaellie M. Cognitive and functional outcome after out of hospital cardiac arrest. J Int Neuropsychol Soc 2011; 17(2): 364-8.
164. Lim C, Alexander MP, LaFleche G, Schnyer DM, Verfaellie M. The neurological and cognitive sequelae of cardiac arrest. Neurology 2004; 63(10): 1774-8.
165. Horstmann A, Frisch S, Jentzsch RT, et al. Resuscitating the heart but losing the brain: brain atrophy in the aftermath of cardiac arrest. Neurology 2010; 74(4): 306-12.
166. Roine RO, Kajaste S, Kaste M. Neuropsychological sequelae of cardiac arrest. JAMA 1993; 269(2): 237-42.
167. Torgersen J, Strand K, Bjelland TW, et al. Cognitive dysfunction and health-related quality of life after a cardiac arrest and therapeutic hypothermia. Acta Anaesthesiol Scand 2010; 54(6): 721-8.
168. Wachelder EM, Moulaert VR, van Heugten C, et al. Life after survival: long-term daily functioning and quality of life after an out-of-hospital cardiac arrest. Resuscitation 2009; 80(5): 517-22.
169. Drysdale EE, Grubb NR, Fox KA, O'Carroll RE. Chronicity of memory impairment in long-term out-of-hospital cardiac arrest survivors. Resuscitation 2000; 47(1): 27-32.
170. Davis HP, Tribuna J, Pulsinelli WA, Volpe BT. Reference and working memory of rats following hippocampal damage induced by transient forebrain ischemia. Physiol Behav 1986; 37(3): 387-92.
171. Roberge MC, Hotte-Bernard J, Messier C, Plamondon H. Food restriction attenuates ischemia-induced spatial learning and memory deficits despite extensive CA1 ischemic injury. Behav Brain Res 2008; 187(1): 123-32.
172. Broadbent NJ, Squire LR, Clark RE. Spatial memory, recognition memory, and the hippocampus. Proc Natl Acad Sci USA 2004; 101(40): 14515-20.
173. Nagahara AH, Otto T, Gallagher M. Entorhinal-perirhinal lesions impair performance of rats on two versions of place learning in the Morris water maze. Behav Neurosci 1995; 109(1): 3-9.
174. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11(1): 47-60.
175. Hickey RW, Akino M, Strausbaugh S, De Courten-Myers GM. Use of the Morris water maze and acoustic startle chamber to evaluate neurologic injury after asphyxial arrest in rats. Pediatr Res 1996; 39(1): 77-84.
176. Olsen GM, Scheel-Kruger J, Moller A, Jensen LH. Relation of spatial learning of rats in the Morris water maze task to the number of viable CA1 neurons following four-vessel occlusion. Behav Neurosci 1994; 108(4): 681-90.
177. Neigh GN, Glasper ER, Kofler J, et al. Cardiac arrest with cardiopulmonary resuscitation reduces dendritic spine density in CA1 pyramidal cells and selectively alters acquisition of spatial memory. Eur J Neurosci 2004; 20(7): 1865-72.
178. Hartman RE, Lee JM, Zipfel GJ, Wozniak DF. Characterizing learning deficits and hippocampal neuron loss following transient global cerebral ischemia in rats. Brain Res 2005; 1043(1-2): 48-56.
179. Yonemori F, Yamaguchi T, Yamada H, Tamura A. Evaluation of a motor deficit after chronic focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1998; 18(10): 1099-106.
180. Wahl F, Allix M, Plotkine M, Boulu RG. Neurological and behavioral outcomes of focal cerebral ischemia in rats. Stroke 1992; 23(2): 267-72.
181. Yamamoto M, Tamura A, Kirino T, Shimizu M, Sano K. Behavioral changes after focal cerebral ischemia by left middle cerebral artery occlusion in rats. Brain Res 1988; 452(1-2): 323-8.
182. Barnes CA. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol 1979; 93(1): 74-104.
183. Wiltgen BJ, Sanders MJ, Anagnostaras SG, Sage JR, Fanselow MS. Context fear learning in the absence of the hippocampus. J Neurosci 2006; 26(20): 5484-91.
184. Sun HS, Jackson MF, Martin LJ, et al. Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci 2009; 12(10): 1300-7.
185. Spieker EA, Astur RS, West JT, Griego JA, Rowland LM. Spatial memory deficits in a virtual reality eight-arm radial maze in schizophrenia. Schizophr Res 2012; 135(1-3): 84-9.
186. Bizon JL, LaSarge CL, Montgomery KS, et al. Spatial reference and working memory across the lifespan of male Fischer 344 rats. Neurobiol Aging 2009; 30(4): 646-55.
187. Freedman M, Oscar-Berman M. Bilateral frontal lobe disease and selective delayed response deficits in humans. Behav Neurosci 1986; 100(3): 337-42.
188. Seamans JK, Floresco SB, Phillips AG. D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J Neurosci 1998; 18(4): 1613-21.
189. Erbil G, Ozbal S, Sonmez U, et al. Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain. Neurosciences (Riyadh) 2008; 13(3): 233-8.
190. Garcia-Chavez D, Gonzalez-Burgos I, Letechipia-Vallejo G, et al. Long-term evaluation of cytoarchitectonic characteristics of prefrontal cortex pyramidal neurons, following global cerebral ischemia and neuroprotective melatonin treatment, in rats. Neurosci Lett 2008; 448(1): 148-52.
191. Delatour B, Gisquet-Verrier P. Prelimbic cortex specific lesions disrupt delayed-variable response tasks in the rat. Behav Neurosci 1996; 110(6): 1282-98.
192. Wikmark RG, Divac I, Weiss R. Retention of spatial delayed alternation in rats with lesions in the frontal lobes. Implications for a comparative neuropsychology of the prefrontal system. Brain Behav Evol 1973; 8(5): 329-39.
193. Johnson CT, Olton DS, Gage FH, 3rd, Jenko PG. Damage to hippocampus and hippocampal connections: effects on DRL and spontaneous alternation. J Comp Physiol Psychol 1977; 91(3): 508-22.
194. Stevens R, Cowey A. Effects of dorsal and ventral hippocampal lesions on spontaneous alternation, learned alternation and probability learning in rats. Brain Res 1973; 52: 203-24.
195. Aggleton JP, Hunt PR, Rawlins JN. The effects of hippocampal lesions upon spatial and non-spatial tests of working memory. Behav Brain Res 1986; 19(2): 133-46.
196. Mariano TY, Bannerman DM, McHugh SB, et al. Impulsive choice in hippocampal but not orbitofrontal cortex-lesioned rats on a nonspatial decision-making maze task. Eur J Neurosci 2009; 30(3): 472-84.
197. Ramirez JJ, Stein DG. Sparing and recovery of spatial alternation performance after entorhinal cortex lesions in rats. Behav Brain Res 1984; 13(1): 53-61.
198. Aggleton JP, Hunt PR, Nagle S, Neave N. The effects of selective lesions within the anterior thalamic nuclei on spatial memory in the rat. Behav Brain Res 1996; 81(1-2): 189-98.
199. Fitz NF, Gibbs RB, Johnson DA. Selective lesion of septal cholinergic neurons in rats impairs acquisition of a delayed matching to position T-maze task by delaying the shift from a response to a place strategy. Brain Res Bull 2008; 77(6): 356-60.
200. Volpe BT, Waczek B, Davis HP. Modified T-maze training demonstrates dissociated memory loss in rats with ischemic hippocampal injury. Behav Brain Res 1988; 27(3): 259-68.
201. Grubb NR, O'Carroll R, Cobbe SM, Sirel J, Fox KA. Chronic memory impairment after cardiac arrest outside hospital. BMJ 1996; 313(7050): 143-6.
202. Kiryk A, Pluta R, Figiel I, et al. Transient brain ischemia due to cardiac arrest causes irreversible long-lasting cognitive injury. Behav Brain Res 2011; 219(1): 1-7.
203. Barr AM, MacLaurin SA, Semenova S, Fish KN, Markou A. Altered performance of reelin-receptor ApoER2 deficient mice on spatial tasks using the Barnes maze. Behav Neurosci 2007; 121(5): 1101-5.
204. Horn M, Schlote W. Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia. Acta Neuropathol 1992; 85(1): 79-87.
205. Hausmann R, Seidl S, Betz P. Hypoxic changes in Purkinje cells of the human cerebellum. Int J Legal Med. 2007; 121(3): 175-83.
206. Cronberg T, Lilja G, Rundgren M, Friberg H, Widner H. Longterm neurological outcome after cardiac arrest and therapeutic hypothermia. Resuscitation 2009; 80(10): 1119-23.
207. Thippeswamy BS, Nagakannan P, Shivasharan BD, et al. Protective effect of embelin from Embelia ribes Burm. against transient global ischemia-induced brain damage in rats. Neurotox Res 2011; 20(4): 379-86.
208. Lin B, Levy S, Raval AP, Perez-Pinzon MA, Defazio RA. Forebrain ischemia triggers GABAergic system degeneration in substantia nigra at chronic stages in rats. Cardiovasc Psychiatry Neurol 2010; 2010: 506952.
209. Pateliya BB, Singh N, Jaggi AS. Possible role of opioids and KATP channels in neuroprotective effect of postconditioning in mice. Biol Pharm Bull 2008; 31(9): 1755-60.
210. Hicks SD, DeFranco DB, Callaway CW. Hypothermia during reperfusion after asphyxial cardiac arrest improves functional recovery and selectively alters stress-induced protein expression. J Cereb Blood Flow Metab 2000; 20(3): 520-30.
211. Milot MR, Plamondon H. Time-dependent effects of global cerebral ischemia on anxiety, locomotion, and habituation in rats. Behav Brain Res 2009; 200(1): 173-80.
212. Schreckinger M, Geocadin RG, Savonenko A, et al. Long-lasting cognitive injury in rats with apparent full gross neurological recovery after short-term cardiac arrest. Resuscitation 2007; 75(1): 105-13.
213. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12(1): 1-21.
214. Sughrue ME, Mocco J, Komotar RJ, et al. An improved test of neurological dysfunction following transient focal cerebral ischemia in rats. J Neurosci Methods 2006; 151(2): 83-9.
215. Albertsmeier M, Teschendorf P, Popp E, et al. Evaluation of a tape removal test to assess neurological deficit after cardiac arrest in rats. Resuscitation 2007; 74(3): 552-8.
216. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008; 455(7215): 894-902.
217. Barbee JG. Mixed symptoms and syndromes of anxiety and depression: diagnostic, prognostic, and etiologic issues. Ann Clin Psychiatry 1998; 10(1): 15-29.
218. Katz RJ, Roth KA, Carroll BJ. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 1981; 5(2): 247-51.
219. Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2007; 2(2): 322-8.
220. Pellow S, Chopin P, File SE, Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14(3): 149-67.
221. Nelson A, Lebessi A, Sowinski P, Hodges H. Comparison of effects of global cerebral ischaemia on spatial learning in the standard and radial water maze: relationship of hippocampal damage to performance. Behav Brain Res 1997; 85(1): 93-115.
222. Yan XB, Wang SS, Hou HL, Ji R, Zhou JN. Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav Brain Res 2007; 177(2): 282-9.
223. Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl) 1994; 116(1): 56-64.
224. Kulkarni SK, Singh K, Bishnoi M. Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs. Methods Find Exp Clin Pharmacol 2007; 29(5): 343-8.
225. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992; 16(4): 525-34.
226. Tiainen M, Poutiainen E, Kovala T, et al. Cognitive and neuro physiological outcome of cardiac arrest survivors treated with therapeutic hypothermia. Stroke 2007; 38(8): 2303-8.
227. Plamondon H, Davignon G, Khan S, Charron C. Cerebral ischemic preconditioning induces lasting effects on CA1 neuronal survival, prevents memory impairments but not ischemia-induced hyperac tivity. Behav Brain Res 2008; 189(1): 145-51.
228. Saklani R, Jaggi A, Singh N. Pharmacological preconditioning by milrinone: memory preserving and neuroprotective effect in ischemia-reperfusion injury in mice. Arch Pharm Res 2010; 33(7): 1049-57.
229. Sun MK, Xu H, Alkon DL. Pharmacological protection of synaptic function, spatial learning, and memory from transient hypoxia in rats. J Pharmacol Exp Ther 2002; 300(2): 408-16.
230. Wang JY, Shen J, Gao Q, et al. Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats. Stroke 2008; 39(3): 983-90.
231. Zhao P, Peng L, Li L, Xu X, Zuo Z. Isoflurane preconditioning improves long-term neurologic outcome after hypoxic-ischemic brain injury in neonatal rats. Anesthesiology 2007; 107(6): 963-70.
232. Girbovan C, Morin L, Plamondon H. Repeated resveratrol adminis tration confers lasting protection against neuronal damage but induces dose-related alterations of behavioral impairments after global ischemia. Behav Pharmacol 2012; 23(1): 1-13.
233. Koerner IP, Gatting M, Noppens R, Kempski O, Brambrink AM. Induction of cerebral ischemic tolerance by erythromycin precon ditioning reprograms the transcriptional response to ischemia and suppresses inflammation. Anesthesiology 2007; 106(3): 538-47.
234. Fagan SC, Cronic LE, Hess DC. Minocycline Development for Acute Ischemic Stroke. Transl Stroke Res 2011; 2(2): 202-8.
235. Shake JG, Peck EA, Marban E, et al. Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection. Ann Thorac Surg 2001; 72(6): 1849-54.
236. Tauskela JS, Fang H, Hewitt M, et al. Elevated synaptic activity preconditions neurons against an in vitro model of ischemia. J Biol Chem 2008; 283(50): 34667-76.
237. Pang J, Itano T, Sumitani K, Negi T, Miyamoto O. Electro acupuncture attenuates both glutamate release and hyperemia after transient ischemia in gerbils. Am J Chin Med 2003; 31(2): 295-303.
238. Yang WO, Huang YL, Da CD, Cheng JS. Electroacupuncture reduces rat's neuronal ischemic injury and enhances the expression of basic fibroblast growth factor. Acupunct Electrother Res 1999; 24(1): 1-10.
239. Li X, Luo P, Wang Q, Xiong L. Electroacupuncture Pretreatment as a Novel Avenue to Protect Brain against Ischemia and Reperfusion Injury. Evid Based Complement Alternat Med 2012; 2012: 195397.
240. Mishima Y, Harada H, Sugiyama K, et al. Induction of neuronal tolerance by electroconvulsive shock in rats subjected to forebrain ischemia. Kurume Med J 2005; 52(4): 153-60.
241. Bernaudin M, Nedelec AS, Divoux D, et al. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in asso ciation with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002; 22(4): 393-403.
242. Ruscher K, Freyer D, Karsch M, et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002; 22(23): 10291-301.
243. Prass K, Scharff A, Ruscher K, et al. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 2003; 34(8): 1981-6.
244. Raval AP, Bramlett H, Perez-Pinzon MA. Estrogen preconditioning protects the hippocampal CA1 against ischemia. Neuroscience 2006; 141(4): 1721-30.
245. Miller NR, Jover T, Cohen HW, Zukin RS, Etgen AM. Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death. Endocrinology 2005; 146(7): 3070-9.
246. Wang Q, Sun AY, Simonyi A, et al. Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radic Biol Med 2007; 43(7): 1048-60.
247. Wang Q, Kalogeris TJ, Wang M, Jones AW, Korthuis RJ. Antecedent ethanol attenuates cerebral ischemia/reperfusioninduced leukocyte-endothelial adhesive interactions and delayed neuronal death: role of large conductance, Ca2+-activated K+ channels. Microcirculation 2010; 17(6): 427-38.
248. Nada SE, Shah ZA. Preconditioning with Ginkgo biloba (EGb 761(R) provides neuroprotection through HO1 and CRMP2. Neurobiol Dis 2012; 46(1): 180-9.
249. Ota A, Ikeda T, Abe K, et al. Hypoxic-ischemic tolerance pheno menon observed in neonatal rat brain. Am J Obstet Gynecol 1998; 179(4): 1075-8.
250. Wada K, Ito M, Miyazawa T, et al. Repeated hyperbaric oxygen induces ischemic tolerance in gerbil hippocampus. Brain Res 1996; 740(1-2): 15-20.
251. Prass K, Wiegand F, Schumann P, et al. Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent. Brain Res 2000; 871(1): 146-50.
252. Li YX, Ding SJ, Xiao L, Guo W, Zhan Q. Desferoxamine precon ditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin. Neurosci Bull 2008; 24(2): 89-95.
253. Hamrick SE, McQuillen PS, Jiang X, et al. A role for hypoxiainducible factor-1alpha in desferoxamine neuroprotection. Neurosci Lett 2005; 379(2): 96-100.
254. Perez-Pinzon MA, Xu GP, Dietrich WD, Rosenthal M, Sick TJ. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J Cereb Blood Flow Metab 1997; 17(2): 175-82.
255. Huang CY, Yang HI, Chen SD, Shaw FZ, Yang DI. Protective effects of lipopolysaccharide preconditioning against nitric oxide neurotoxicity. J Neurosci Res 2008; 86(6): 1277-89.
256. Lin HY, Huang CC, Chang KF. Lipopolysaccharide precon ditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat. Pediatr Res 2009; 66(3): 254-9.
257. Heurteaux C, Bertaina V, Widmann C, Lazdunski M. K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci USA 1993; 90(20): 9431-5.
258. Lauritzen I, De Weille JR, Lazdunski M. The potassium channel opener (-)-cromakalim prevents glutamate-induced cell death in hippocampal neurons. J Neurochem 1997; 69(4): 1570-9.
259. Chan MT, Boet R, Ng SC, Poon WS, Gin T. Magnesium sulfate for brain protection during temporary cerebral artery occlusion. Acta Neurochir Suppl 2005; 95: 107-11.
260. Gaspar T, Kis B, Snipes JA, et al. Neuronal preconditioning with the antianginal drug, bepridil. J Neurochem 2007; 102(3): 595-608.
261. Riepe MW, Ludolph AC. Chemical preconditioning: a cytoprotec tive strategy. Mol Cell Biochem 1997; 174(1-2): 249-54.
262. Sugino T, Nozaki K, Takagi Y, Hashimoto N. 3-Nitropropionic acid induces ischemic tolerance in gerbil hippocampus in vivo. Neurosci Lett 1999; 259(1): 9-12.
263. Tang LH, Xia ZY, Zhao B, et al. Phosphocreatine preconditioning attenuates apoptosis in ischemia-reperfusion injury of rat brain. J Biomed Biotechnol 2011; 2011: 107091.
264. Kanoria S, Glantzounis G, Quaglia A, et al. Remote precondi tioning improves hepatic oxygenation after ischaemia reperfusion injury. Transpl Int 2012; 25(7): 783-91.
265. Desai M, Gurusamy KS, Ghanbari H, Hamilton G, Seifalian AM. Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures. Cochrane Database Syst Rev 2011(12): CD008472.
266. Candilio L, Hausenloy DJ, Yellon DM. Remote ischemic conditio ning: a clinical trial's update. J Cardiovasc Pharmacol Ther 2011; 16(3-4): 304-12.
267. Della-Morte D, Dave KR, DeFazio RA, et al. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009; 159 (3): 993-1002.
268. Tan L, Yu JT, Guan HS. Resveratrol exerts pharmacological preconditioning by activating PGC-1alpha. Med Hypotheses 2008; 71(5): 664-7.
269. Dong W, Li N, Gao D, et al. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J Vasc Surg 2008; 48(3): 709-14.
270. Carloni S, Girelli S, Buonocore G, Longini M, Balduini W. Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation. Exp Neurol 2009; 220(1): 82-9.
271. Kuroiwa T, Yamada I, Endo S, Hakamata Y, Ito U. 3-Nitro propionic acid preconditioning ameliorates delayed neurological deterioration and infarction after transient focal cerebral ischemia in gerbils. Neurosci Lett 2000; 283(2): 145-8.
272. Striggow F, Riek M, Breder J, et al. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci USA 2000; 97(5): 2264-9.
273. Vaughan PJ, Pike CJ, Cotman CW, Cunningham DD. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 1995; 15(7 Pt 2): 5389-401.
274. Bahjat FR, Williams-Karnesky RL, Kohama SG, et al. Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke. J Cereb Blood Flow Metab 2011; 31(5): 1229-42.
275. Leung PY, Stevens SL, Packard AE, et al. Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke 2012; 43(5): 1383-9.
276. Marsh BJ, Stenzel-Poore MP. Toll-like receptors: novel pharma cological targets for the treatment of neurological diseases. Curr Opin Pharmacol 2008; 8(1): 8-13.
277. Bae CY, Sun HS. TRPM7 in cerebral ischemia and potential target for drug development in stroke. Acta Pharmacol Sin 2011; 32(6): 725-33.
278. Zhu W, Wang L, Zhang L, et al. Isoflurane preconditioning neuro protection in experimental focal stroke is androgen-dependent in male mice. Neuroscience 2010; 169(2): 758-69.
279. Wang H, Lu S, Yu Q, et al. Sevoflurane preconditioning confers neuroprotection via anti-inflammatory effects. Front Biosci (Elite Ed) 2011; 3: 604-15.
280. Adamczyk S, Robin E, Simerabet M, et al. Sevoflurane pre-and post-conditioning protect the brain via the mitochondrial K ATP channel. Br J Anaesth 2010; 104(2): 191-200.
281. Kitano H, Kirsch JR, Hurn PD, Murphy SJ. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab 2007; 27(6): 1108-28.